Seyitler Kimya Sanayi AS - Asset Resilience Ratio

Latest as of September 2025: 42.23%

Seyitler Kimya Sanayi AS (SEYKM) has an Asset Resilience Ratio of 42.23% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Seyitler Kimya Sanayi AS (SEYKM) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

TL224.99 Million
≈ $5.04 Million USD Cash + Short-term Investments

Total Assets

TL532.79 Million
≈ $11.93 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Seyitler Kimya Sanayi AS's Asset Resilience Ratio has changed over time. See Seyitler Kimya Sanayi AS (SEYKM) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Seyitler Kimya Sanayi AS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SEYKM market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents TL0.00 0%
Short-term Investments TL224.99 Million 42.23%
Total Liquid Assets TL224.99 Million 42.23%

Asset Resilience Insights

  • Very High Liquidity: Seyitler Kimya Sanayi AS maintains exceptional liquid asset reserves at 42.23% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Seyitler Kimya Sanayi AS Industry Peers by Asset Resilience Ratio

Compare Seyitler Kimya Sanayi AS's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Teleflex Incorporated
NYSE:TFX
Medical Instruments & Supplies 4.50%
Touchstone International Medical Science Co Ltd
SHG:688013
Medical Instruments & Supplies 37.86%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%
Crossject
PA:ALCJ
Medical Instruments & Supplies 1.31%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 4.42%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 51.82%
SDI Ltd
AU:SDI
Medical Instruments & Supplies 6.36%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%

Annual Asset Resilience Ratio for Seyitler Kimya Sanayi AS (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Seyitler Kimya Sanayi AS.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 41.13% TL179.27 Million
≈ $4.02 Million
TL435.84 Million
≈ $9.76 Million
+20.81pp
2023-12-31 20.33% TL83.07 Million
≈ $1.86 Million
TL408.70 Million
≈ $9.15 Million
-8.10pp
2022-12-31 28.43% TL56.60 Million
≈ $1.27 Million
TL199.08 Million
≈ $4.46 Million
+3.28pp
2021-12-31 25.15% TL23.82 Million
≈ $533.45K
TL94.70 Million
≈ $2.12 Million
-4.10pp
2020-12-31 29.25% TL21.04 Million
≈ $471.35K
TL71.96 Million
≈ $1.61 Million
+20.78pp
2019-12-31 8.47% TL3.14 Million
≈ $70.28K
TL37.06 Million
≈ $830.04K
+3.98pp
2015-12-31 4.49% TL796.00K
≈ $17.83K
TL17.72 Million
≈ $396.95K
--
pp = percentage points

About Seyitler Kimya Sanayi AS

IS:SEYKM Turkey Medical Instruments & Supplies
Market Cap
$23.97 Million
TL1.07 Billion TRY
Market Cap Rank
#24458 Global
#439 in Turkey
Share Price
TL5.35
Change (1 day)
-6.14%
52-Week Range
TL2.76 - TL7.63
All Time High
TL7.63
About

Seyitler Kimya Sanayi A.S. develops and sells medical adhesive tape products in Turkey. The company offers health medical plasters, first aid patches, wound dressings, dialysis kits, eye pads, capsicum, and rheumatism plasters used in health institutions. It also provides surgical tapes, first aid strips, band-aid, biocidal products, disposable surgical products, injection series, and wound care … Read more